Skip to main content
Cytogen, Inc. logo

Cytogen, Inc. — Investor Relations & Filings

Ticker · 217330 ISIN · KR7217330000 KO Manufacturing
Open in API
Filings indexed 437 across all filing types
Latest filing 2022-06-27 Capital/Financing Update
Country KR South Korea
Listing KO 217330

About Cytogen, Inc.

https://www.cytogenlab.com/

Cytogen, Inc. is a biotechnology company specializing in liquid biopsy platforms for precision oncology. The company has developed proprietary technology for the rapid isolation and analysis of viable Circulating Tumor Cells (CTCs) from whole blood. Its core offering, the SmartBiopsy Platform, utilizes a high-density microporous chip with microfluidics and nanotechnology to capture CTCs efficiently. This non-invasive diagnostic approach is designed to support early cancer detection, treatment monitoring, and the advancement of personalized medicine for cancer patients.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득(제3회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) regarding the 'Acquisition of Convertible Bonds before Maturity' (Call Option exercise). This relates to the company's capital structure and debt management. Among the provided categories, 'CAP' (Capital/Financing Update) is the most appropriate classification as it covers updates on financing activities and capital structure changes, specifically regarding the redemption/acquisition of debt instruments.
2022-06-27 Korean
불성실공시법인지정예고(공시불이행 3건)
Regulatory Filings Classification · 100% confidence The document is a formal notice from the KOSDAQ exchange regarding the 'designation of an unfaithful disclosure corporation' (불성실공시법인지정예고) due to failure to disclose share collateral contracts. This is a regulatory announcement concerning compliance and disclosure obligations, which does not fit into specific categories like financial reports or shareholder meetings. Therefore, it is classified as a Regulatory Filing (RNS).
2022-06-23 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Sohn Young-woong) of Cytogen. This type of filing, which details personal share transactions by company directors and executives, is classified as 'Director's Dealing' (DIRS) in the provided schema.
2022-05-30 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서). This is a regulatory filing required by the Financial Supervisory Service (FSS) in South Korea when company insiders (directors/executives) trade their own company's shares. This falls under the category of 'Director's Dealing' (DIRS), as it details personal share transactions by a company executive (Sohn Young-woong).
2022-05-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share ownership changes of a specific executive (Sohn Young-woong) of the company Cytogen. This type of filing is a standard regulatory requirement for insiders (directors/executives) to disclose their personal share transactions or changes in holdings, which corresponds to the 'Director's Dealing' category.
2022-05-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. This document details changes in share ownership by a major shareholder (Jeon Byung Hee) and their special related parties in the company Cytogen. It includes specific sections for reporting shareholding status, changes in shareholding, and details of collateral contracts. This type of filing is classified as a Major Shareholding Notification (MRQ) in the provided schema.
2022-05-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.